- Home
- RLMD vs FCUV Comparison
RLMD vs FCUV Comparison
Compare RLMD & FCUV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLMD
- FCUV
- Stock Information
- Founded
- RLMD 2004
- FCUV 2012
- Country
- RLMD United States
- FCUV United States
- Employees
- RLMD N/A
- FCUV N/A
- Industry
- RLMD Biotechnology: Pharmaceutical Preparations
- FCUV Industrial Machinery/Components
- Sector
- RLMD Health Care
- FCUV Industrials
- Exchange
- RLMD Nasdaq
- FCUV Nasdaq
- Market Cap
- RLMD 20.3M
- FCUV 16.7M
- IPO Year
- RLMD N/A
- FCUV N/A
- Fundamental
- Price
- RLMD $0.63
- FCUV $1.94
- Analyst Decision
- RLMD Buy
- FCUV
- Analyst Count
- RLMD 3
- FCUV 0
- Target Price
- RLMD $5.00
- FCUV N/A
- AVG Volume (30 Days)
- RLMD 142.9K
- FCUV 21.9K
- Earning Date
- RLMD 08-07-2025
- FCUV 08-12-2025
- Dividend Yield
- RLMD N/A
- FCUV N/A
- EPS Growth
- RLMD N/A
- FCUV N/A
- EPS
- RLMD N/A
- FCUV N/A
- Revenue
- RLMD N/A
- FCUV $432,983.00
- Revenue This Year
- RLMD N/A
- FCUV N/A
- Revenue Next Year
- RLMD N/A
- FCUV N/A
- P/E Ratio
- RLMD N/A
- FCUV N/A
- Revenue Growth
- RLMD N/A
- FCUV 140.82
- 52 Week Low
- RLMD $0.24
- FCUV $1.69
- 52 Week High
- RLMD $3.98
- FCUV $10.90
- Technical
- Relative Strength Index (RSI)
- RLMD 51.70
- FCUV 31.55
- Support Level
- RLMD $0.59
- FCUV $1.87
- Resistance Level
- RLMD $0.64
- FCUV $2.23
- Average True Range (ATR)
- RLMD 0.05
- FCUV 0.18
- MACD
- RLMD 0.00
- FCUV 0.01
- Stochastic Oscillator
- RLMD 55.00
- FCUV 10.01
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
About FCUV Focus Universal Inc.
Focus Universal Inc offers smart devices, IoT products, and patented products and technologies for 5G telecommunications and network security. It is focused on commercializing its universal smart technology and financial reporting software. Its product line includes various digital, analog, and quantum light meters and filtration products, the Ubiquitor universal smart device, SEC Financial Reporting Software, and other smart devices and sensors. The company's reportable segments are Corporate and IoT, which derives maximum revenue, and Perfecular and Lusher. The Corporate and IoT segment includes its LED and IoT installation and management business (under Smart AVX), specializing in LED and display systems, home theaters, lighting control, automation, and integration.